Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.68 | N/A |
| PEG Ratio (TTM) | -8.01 | N/A |
| P/S Ratio (TTM) | 0.35 | N/A |
| P/B Ratio (TTM) | 1.24 | N/A |
| P/FCF Ratio (TTM) | -13.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.20 | N/A |
| Price to 5YR AVG FCF Ratio | 28.31 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.63% | N/A |
| ROE (TTM) | 4.19% | N/A |
| Net Profit Margin (TTM) | 1.20% | N/A |
| ROIC 5YR AVG | 4.25% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 345.57% | 143.76% | 90.75% |
| Revenue | 2.60% | 10.87% | 11.94% |
| Net Income | 345.84% | 182.55% | 114.83% |
| Cash Flow | 59.38% | 17.78% | 25.79% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.46 | N/A |
| Quick Ratio (TTM) | 0.33 | N/A |
| D/E Ratio (TTM) | 0.40 | N/A |
| Interest Coverage (TTM) | 3.77 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.16 | N/A |
| LTL to 5YR AVG FCF | 24.97 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.01% | N/A |